ULTRAGENYX PHARMACEUTICAL INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -49.2% | -49.2% | -29.8% |
| FY2022 | -201.0% | -201.0% | -45.8% |
| FY2023 | -220.7% | -220.7% | -40.7% |
| FY2024 | -223.1% | -223.1% | -37.9% |
| FY2025 | 718.8% | 718.8% | -37.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -49.2% | -49.2% | -29.8% |
| FY2022 | -201.0% | -201.0% | -45.8% |
| FY2023 | -220.7% | -220.7% | -40.7% |
| FY2024 | -223.1% | -223.1% | -37.9% |
| FY2025 | 718.8% | 718.8% | -37.5% |